Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00630955 · ClinicalTrials.gov registry record · Phase 2
Family History Study of Alcohol Consumption Using Memantine
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 111
- Enrollment target
NCT00630955 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 111 participants.
The verdict
NCT00630955, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of the study medication, memantine (placebo, 20 mg or 40 mg/day) on alcohol drinking behavior in a laboratory setting in which participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. We hypothesize that memantine will reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period. We will also evaluate the influence of family history of alcoholism on the efficacy of memantine in reducing alcohol drinking behavior.
Interventions
- DRUG Placebo
- DRUG Memantine
- DRUG memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00630955
The ClinicalTrials.gov registry entry for NCT00630955 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00630955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00630955 about?
NCT00630955 is a clinical study titled "Family History Study of Alcohol Consumption Using Memantine". The purpose of this study is to evaluate the effects of the study medication, memantine (placebo, 20 mg or 40 mg/day) on alcohol drinking behavior in a laboratory setting in which participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hou...
What is the current status of trial NCT00630955?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 111 participants. The study started on 2006-06. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00630955?
The interventions under investigation include: Placebo (DRUG), Memantine (DRUG), memantine (DRUG).
Who is sponsoring clinical trial NCT00630955?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.